0001213900-23-093857.txt : 20231206
0001213900-23-093857.hdr.sgml : 20231206
20231206214336
ACCESSION NUMBER: 0001213900-23-093857
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231130
FILED AS OF DATE: 20231206
DATE AS OF CHANGE: 20231206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Exploration Capital Fund, LP
CENTRAL INDEX KEY: 0001799866
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21088
FILM NUMBER: 231470961
BUSINESS ADDRESS:
STREET 1: 250 EAST 200 SOUTH
STREET 2: FLOOR 16
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84111
BUSINESS PHONE: 2122204444
MAIL ADDRESS:
STREET 1: 250 EAST 200 SOUTH
STREET 2: FLOOR 16
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Exploration Capital, LLC
CENTRAL INDEX KEY: 0002003514
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21088
FILM NUMBER: 231470960
BUSINESS ADDRESS:
STREET 1: 250 EAST 200 SOUTH, FLOOR 16
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84111
BUSINESS PHONE: (212) 220-4444
MAIL ADDRESS:
STREET 1: 250 EAST 200 SOUTH, FLOOR 16
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Exploration Capital General Partner, LLC
CENTRAL INDEX KEY: 0002003481
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21088
FILM NUMBER: 231470959
BUSINESS ADDRESS:
STREET 1: 250 EAST 200 SOUTH, FLOOR 16
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84111
BUSINESS PHONE: (212) 220-4444
MAIL ADDRESS:
STREET 1: 250 EAST 200 SOUTH, FLOOR 16
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fresh Tracks Therapeutics, Inc.
CENTRAL INDEX KEY: 0000819050
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 930948554
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5777 CENTRAL AVENUE
STREET 2: SUITE 102
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (720) 505-4755
MAIL ADDRESS:
STREET 1: 5777 CENTRAL AVENUE
STREET 2: SUITE 102
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: Brickell Biotech, Inc.
DATE OF NAME CHANGE: 20190830
FORMER COMPANY:
FORMER CONFORMED NAME: VICAL INC
DATE OF NAME CHANGE: 19940211
3
1
marketforms-63735.xml
PRIMARY DOCUMENT
X0206
3
2023-11-30
0
0000819050
Fresh Tracks Therapeutics, Inc.
FRTX
0001799866
Exploration Capital Fund, LP
250 EAST 200 SOUTH
FLOOR 16
SALT LAKE CITY
UT
84111
false
false
true
false
0002003514
Exploration Capital, LLC
250 EAST 200 SOUTH, FLOOR 16
SALT LAKE CITY
UT
84111
false
false
true
false
0002003481
Exploration Capital General Partner, LLC
250 EAST 200 SOUTH FLOOR 16
SALT LAKE CITY
UT
84111
false
false
true
false
Common Stock
670000
D
Exploration Capital, LLC ("X-Cap") is the investment manager of Exploration Capital Fund, LP (the "Partnership") and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Exploration Capital General Partner, LLC (the "GP") is the general partner of the Partnership and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership.
Stephen L. Gustin is the Managing Partner of X-Cap and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Mr. Gustin disclaims beneficial ownership of the reported securities held by the Partnership except to the extent of his pecuniary interest.
Stephen L. Gustin on behalf of Exploration Capital Fund, LP
2023-12-06
Stephen L. Gustin on behalf of Exploration Capital, LLC
2023-12-06
Stephen L. Gustin on behalf of Exploration Capital General Partner, LLC
2023-12-06